跳转至内容
Merck
CN

MAK136

Sigma-Aldrich

单胺氧化酶活性检测试剂盒

sufficient for 100 fluorometric tests

别名:

MAO 检测试剂盒

登录查看公司和协议定价


About This Item

UNSPSC代码:
12161503
NACRES:
NA.84

用途

sufficient for 100 fluorometric tests

检测方法

fluorometric

相关疾病

neurological disorders

储存温度

−20°C

一般描述

单胺氧化酶 (MAO,EC 1.4.3.4) 是一类可催化单胺氧化脱氨反应的线粒体酶。在哺乳动物中,MAO 由 MAO-A 和 MAO-B 两种同工酶组成。 MAO功能障碍被认为是造成许多神经系统疾病的原因。 体内 MAO 水平过高或过低与抑郁症、精神分裂症、药物滥用、注意力缺陷障碍、偏头痛和不规律性成熟有关。MAO 抑制剂是治疗抑郁症的主要处方药之一。

应用

单胺氧化酶活性测定试剂盒已用于评估 MAO-A(单胺氧化酶 A)、MAO-B(单胺氧化酶 B) 和 ALDH(乙醛脱氢酶)活性。

特点和优势

兼容高通量的操作系统。

适用性

可用于测定生物样品中的MAO 活性以及筛选MAO 抑制剂。可分别测定MAO-A 和 MAO-B的活性或同时测定两者的活性。

原理

单胺氧化酶测定试剂盒为测定生物样品中 MAO 酶活性提供了一种方便的荧光测定法。在试验中,MAO 与 对酪胺(MAO-A 和 MAO-B 的底物)反应,生成 H 2 O 2 ,可通过荧光法(λex = 530/λ em = 585 nm)测定。该测定方法简便、灵敏、稳定、且具有高通量适应性。单位定义:在测定条件下,一个单位的MAO每分钟催化形成1μ摩尔H 2 O 2

储存分类代码

10 - Combustible liquids

法规信息

动植物源性产品

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Lovedeep Singh et al.
Metabolic brain disease, 36(1), 111-121 (2020-09-02)
Pain and depression are often co-existing pathological states that promote mutual severity resulting in limited efficacy of current treatment strategies. Thus, there is a need to develop an efficacious alternate treatment regimen for pain-depression dyad. Skimmetin and osthole are molecules
Proteome Profiling of Primary Pancreatic Ductal Adenocarcinomas Undergoing Additive Chemoradiation Link ALDH1A1 to Early Local Recurrence and Chemoradiation Resistance.
Oria V O, et al.
Translational Oncology, 11(6), 1307-1322 (2018)
Umut Salgin-Goksen et al.
Journal of medicinal chemistry, 64(4), 1989-2009 (2021-02-04)
Thirty compounds having 1-[2-(5-substituted-2-benzoxazolinone-3-yl) acetyl]-3,5-disubstitutedphenyl-2-pyrazoline structure and nine compounds having N'-(1,3-disubstitutedphenylallylidene)-2-(5-substituted-2-benzoxazolinone-3-yl)acetohydrazide skeleton were synthesized and evaluated as monoamine oxidase (MAO) inhibitors. All of the compounds exhibited selective MAO-A inhibitor activity in the nanomolar or low micromolar range. The results of
Juho-Matti Renko et al.
Molecular neurobiology, 55(8), 6755-6768 (2018-01-20)
Neurotrophic factors (NTFs) hold potential as disease-modifying therapies for neurodegenerative disorders like Parkinson's disease. Glial cell line-derived neurotrophic factor (GDNF), cerebral dopamine neurotrophic factor (CDNF), and mesencephalic astrocyte-derived neurotrophic factor (MANF) have shown neuroprotective and restorative effects on nigral dopaminergic
Mesencephalic Astrocyte-Derived Neurotrophic Factor (MANF) Elevates Stimulus-Evoked Release of Dopamine in Freely-Moving Rats.
Renko J M, et al.
Molecular Neurobiology, 1-14 (2018)

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门